Gene · 4157
Papers3,724
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 3,724
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Hydrolyzed Conchiolin Protein (HCP) Extracted from Pearls Antagonizes both ET-1 and α-MSH for Skin Whitening. | Int J Mol Sci | 2023 | 37108635 | PubTator, text mining | PubMed |
| Melanoma risk prediction based on a polygenic risk score and clinical risk factors. | Melanoma Res | 2023 | 37096571 | PubTator, text mining | PubMed |
| Computational Screening of Approved Drugs for Inhibition of the Antibiotic Resistance Gene mecA in Methicillin-Resistant Staphylococcus aureus (MRSA) Strains. | BioTech (Basel) | 2023 | 37092469 | PubTator, text mining | PubMed |
| Proteomic profiling of cutaneous melanoma explains the aggressiveness of distant organ metastasis. | Exp Dermatol | 2023 | 37082900 | PubTator, text mining | PubMed |
| Absorption, metabolism, and excretion of [14 C]dersimelagon, an investigational oral selective melanocortin 1 receptor agonist, in preclinical species and healthy volunteers. | Pharmacol Res Perspect | 2023 | 37078227 | PubTator, text mining | PubMed |
| Results From a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Repository Corticotropin Injection for the Treatment of Pulmonary Sarcoidosis. | Pulm Ther | 2023 | 37072607 | PubTator, text mining | PubMed |
| A frame-shift mutation in COMTD1 is associated with impaired pheomelanin pigmentation in chicken. | PLoS Genet | 2023 | 37068079 | PubTator, text mining | PubMed |
| Acthar Gel Inhibits the Activation of CD4+ and CD8+ T Cells. | J Interferon Cytokine Res | 2023 | 37062818 | PubTator, text mining | PubMed |
| Results from a first-in-human study of dersimelagon, an investigational oral selective MC1R agonist. | Eur J Clin Pharmacol | 2023 | 37060458 | PubTator, text mining | PubMed |
| The αMSH-Dependent PI3K Pathway Supports Energy Metabolism, via Glucose Uptake, in Melanoma Cells. | Cells | 2023 | 37048170 | PubTator, text mining | PubMed |
| Dersimelagon in Erythropoietic Protoporphyrias. | N Engl J Med | 2023 | 37043653 | PubTator, text mining | PubMed |
| Qualitative assessment of uptake retention and evaluation of prevention materials for skin cancer among Hispanics. | Patient Educ Couns | 2023 | 37028174 | PubTator, text mining | PubMed |
| Association of genetically-predicted placental gene expression with adult blood pressure traits. | J Hypertens | 2023 | 37016918 | PubTator, text mining | PubMed |
| Nevus Count, Pigmentary Characteristics, and Melanoma-specific Mortality among Norwegian Women with Melanoma >1.0 mm Thick. | Acta Derm Venereol | 2023 | 37014267 | PubTator, text mining | PubMed |
| An evaluation of setmelanotide injection for chronic weight management in adult and pediatric patients with obesity due to Bardet-Biedl syndrome. | Expert Opin Pharmacother | 2023 | 37013719 | PubTator, text mining | PubMed |
| Stress decreases spermatozoa quality and induces molecular alterations in zebrafish progeny. | BMC Biol | 2023 | 37013516 | PubTator, text mining | PubMed |
| Comparative oncology: overcoming human cancer through companion animal studies. | Exp Mol Med | 2023 | 37009802 | PubTator, text mining | PubMed |
| In Vivo evaluation of newly synthesized 213Bi-conjugated alpha-melanocyte stimulating hormone (α-MSH) peptide analogues in melanocortin-1 receptor (MC1-R) positive experimental melanoma model. | J Pharm Biomed Anal | 2023 | 37001274 | PubTator, text mining | PubMed |
| Drug Delivery Strategies for Avobenzone: A Case Study of Photostabilization. | Pharmaceutics | 2023 | 36986867 | PubTator, text mining | PubMed |
| Prospects of Using Protein Engineering for Selective Drug Delivery into a Specific Compartment of Target Cells. | Pharmaceutics | 2023 | 36986848 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4157/papers?page=20